KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Net Cash Flow (2017 - 2025)

Elanco Animal Health (ELAN) has disclosed Net Cash Flow for 9 consecutive years, with $26.0 million as the latest value for Q4 2025.

  • Quarterly Net Cash Flow fell 52.73% to $26.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.0 million through Dec 2025, down 97.1% year-over-year, with the annual reading at $6.0 million for FY2025, 97.1% down from the prior year.
  • Net Cash Flow hit $26.0 million in Q4 2025 for Elanco Animal Health, up from -$35.0 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $193.0 million in Q4 2021 to a low of -$291.0 million in Q1 2022.
  • Historically, Net Cash Flow has averaged $5.9 million across 5 years, with a median of $18.5 million in 2024.
  • Biggest five-year swings in Net Cash Flow: tumbled 955.88% in 2022 and later skyrocketed 1220.0% in 2024.
  • Year by year, Net Cash Flow stood at $193.0 million in 2021, then crashed by 176.17% to -$147.0 million in 2022, then skyrocketed by 88.44% to -$17.0 million in 2023, then surged by 423.53% to $55.0 million in 2024, then tumbled by 52.73% to $26.0 million in 2025.
  • Business Quant data shows Net Cash Flow for ELAN at $26.0 million in Q4 2025, -$35.0 million in Q3 2025, and $25.0 million in Q2 2025.